A Combination of the Pediatric NAFLD Fibrosis Index and Enhanced Liver Fibrosis Test Identifies Children With Fibrosis

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 2, 2011, Pages

  Alkhouri, Naim ^a   Carter Kent, Christine ^a   Lopez, Rocio ^a   Rosenberg, William M ^b   Pinzani, Massimo ^c   Bedogni, Giorgio ^d,e   Feldstein, Ariel E ^a   Nobili, Valerio ^f  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Liver Research Center   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Diagnostic Algorithm; Histological Severity; Nonalcoholic Steatohepatitis (NASH); Noninvasive Tests

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYALURONIC ACID; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ARTICLE; CHILD; CLINICAL ASSESSMENT; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENHANCED LIVER FIBROSIS TEST; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; PEDIATRIC NAFLD FIBROSIS INDEX; PEDIATRICS; RECEIVER OPERATING CHARACTERISTIC; WAIST CIRCUMFERENCE;

EID: 78751705424     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.09.015     Document Type: Article

References (39)

1. Chan D.F., Li A.M., Chu W.C., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004, 28:1257-1263.
2. Schwimmer J.B., Deutsch R., Kahen T., et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006, 118:1388-1393.
3. Wieckowska A., Feldstein A.E. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 2005, 17:636-641.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
5. Feldstein A.E., Charatcharoenwitthaya P., Treeprasertsuk S., et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009, 58:1538-1544.
6. Nobili V., Marcellini M., Devito R., et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006, 44:458-465.
7. Angulo P., Hui J.M., Marchesini G., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007, 45:846-854.
8. Guha I.N., Parkes J., Roderick P., et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008, 47:455-460.
9. Ratziu V., Giral P., Charlotte F., et al. Liver fibrosis in overweight patients. Gastroenterology 2000, 118:1117-1123.
10. Shah A.G., Lydecker A., Murray K., et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009, 7:1104-1112.
11. Wieckowska A., McCullough A.J., Feldstein A.E. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. J Hepatol 2007, 46:582-589.
12. Harrison S.A., Oliver D., Arnold H.L., et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008, 57:1441-1447.
13. Nobili V., Alisi A., Vania A., et al. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease. BMC Med 2009, 7:21.
14. Nobili V., Parkes J., Bottazzo G., et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 2008, 136:160-167.
15. Nobili V., Manco M., Devito R., et al. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006, 24:1553-1561.
16. Manco M., Nobili V. Intensive treatment and dietary fats in adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008, 46:224.
17. Kuczmarski R.J., Ogden C.L., Grummer-Strawn L.M., et al. CDC growth charts: United States. Adv Data 2000, 1-27.
18. Cole T.J., Bellizzi M.C., Flegal K.M., et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000, 320:1240-1243.
19. Boney C.M., Verma A., Tucker R., et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115:e290-e296.
20. Fernandez J.R., Redden D.T., Pietrobelli A., et al. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004, 145:439-444.
21. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992, 89:525-584. American Academy of Pediatrics.
22. Report of the Second Task Force on Blood Pressure Control in Children--1987. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987, 79:1-25. Task Force on Blood Pressure Control in Children.
23. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
24. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
25. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
26. Poynard T., Halfon P., Castera L., et al. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 2007, 25:733-739.
27. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
28. Jankowska I., Socha P., Pawlowska J., et al. Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy. Pediatr Transplant 2007, 11:796-798.
29. Jonas M.M., Krawczuk L.E., Kim H.B., et al. Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome. Liver Transplant 2005, 11:108-110.
30. Molleston J.P., White F., Teckman J., et al. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002, 97:2460-2462.
31. Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 2010, 51:373-375.
32. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, 44:865-873.
33. Soderberg C., Stal P., Askling J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
34. Ratziu V., Charlotte F., Heurtier A., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005, 128:1898-1906.
35. Rockey D.C., Caldwell S.H., Goodman Z.D., et al. Liver biopsy. Hepatology 2009, 49:1017-1044.
36. Iacobellis A., Marcellini M., Andriulli A., et al. Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis. World J Gastroenterol 2006, 12:7821-7825.
37. Nobili V., Vizzutti F., Arena U., et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008, 48:442-448.
38. Adams L. Transient elastography in nonalcoholic fatty liver disease: making sense of echoes. Hepatology 2010, 51:370-372.
39. Carter-Kent C., Yerian L.M., Brunt E.M., et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 2009, 50:1113-1120.